Analysis, Bioservo Technologies: Giving a helping hand

Bioservo has a global edge position within soft exoskelton technologies. The company’s products focus on reducing risks for work related strain injuries and rehabilitiation within the healthcare sector. The company is well positioned to take advantage of the expected growth in the market. Our target price in the base case scenario is 29 kronor per share.

Read the full report here. (Swedish)